S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
Log in
NASDAQ:LHDX

Lucira Health Stock Forecast, Price & News

$18.27
-1.12 (-5.78 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.39
Now: $18.27
$19.20
50-Day Range N/A
52-Week Range
$17.39
Now: $18.27
$37.99
Volume306,693 shs
Average Volume478,045 shs
Market Capitalization$675.31 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It has developed a testing platform that produces COVID-19 single-use test kit with molecular accuracy. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was founded in 2013 and is headquartered in Emeryville, California.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LHDX
CUSIPN/A
CIKN/A
Phone510 350 8071
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$675.31 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.83 out of 5 stars

Medical Sector

1124th out of 1,968 stocks

Diagnostics & Research Industry

4th out of 13 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
$18.27
-1.12 (-5.78 %)
(As of 03/2/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LHDX News and Ratings via Email

Sign-up to receive the latest news and ratings for LHDX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lucira Health (NASDAQ:LHDX) Frequently Asked Questions

What stocks does MarketBeat like better than Lucira Health?

Wall Street analysts have given Lucira Health a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lucira Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Lucira Health's key executives?

Lucira Health's management team includes the following people:
  • Mr. Erik T. Engelson, Pres, CEO & Director (Age 61)
  • Mr. Daniel V. George, CFO & Treasurer (Age 51)
  • Ms. Tamanna Prashar, VP of Global Supply Chain, Operations & Quality (Age 39)
  • Dr. Debkishore Mitra Ph.D., CTO & Director (Age 34)
  • Ms. Kelly Lewis Brezoczky, Exec. VP of Commercialization, Regulatory, Clinical & Bus. Devel. (Age 57)

Who are some of Lucira Health's key competitors?

When did Lucira Health IPO?

(LHDX) raised $125 million in an initial public offering (IPO) on Friday, February 5th 2021. The company issued 7,800,000 shares at a price of $15.00-$17.00 per share. BofA Securities, William Blair and LifeSci Capital served as the underwriters for the IPO.

What is Lucira Health's stock symbol?

Lucira Health trades on the NASDAQ under the ticker symbol "LHDX."

When does the company's quiet period expire?

Lucira Health's quiet period expires on Wednesday, March 17th. Lucira Health had issued 9,000,000 shares in its IPO on February 5th. The total size of the offering was $153,000,000 based on an initial share price of $17.00. During the company's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Lucira Health?

Shares of LHDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lucira Health's stock price today?

One share of LHDX stock can currently be purchased for approximately $18.27.

How much money does Lucira Health make?

Lucira Health has a market capitalization of $675.31 million.

What is Lucira Health's official website?

The official website for Lucira Health is www.lucirahealth.com.

How can I contact Lucira Health?

The company can be reached via phone at 510 350 8071.


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.